Veltman J A, van Weert I, Aubele M, Bot F J, Ramaekers F C, Manni J J, Hopman A H
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Maastricht, Maastricht, The Netherlands.
Int J Cancer. 2001 Jan 15;91(2):193-9. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1029>3.3.co;2-5.
Laryngeal squamous-cell carcinoma is often preceded by pre-malignant lesions. In this study, pre-malignant as well as malignant laryngeal lesions were analyzed using p53 immunohistochemistry and in situ hybridization for chromosomes 1, 7, 9, 17 and 18. Microsatellite analysis was performed on laser-microdissected tissue fragments with the aim of studying loss of heterozygosity (LOH) of 9p21, 17p13 and 18q21. Sequential biopsies were analyzed from a few cases to study genetic progression in more detail. The following genetic progression patterns were observed: (i) histologically normal mucosa and hyperplastic lesions without malignant progression were typically disomic for all chromosomes tested and showed no or only basal cell layer positivity for p53 and no allelic loss; (ii) hyperplastic lesions preceding dysplastic/invasive growth frequently showed trisomy for chromosome 7 and LOH of 9p21 and 17p13, and small foci within these lesions sometimes showed tetraploidization and p53 positivity; (iii) dysplastic lesions were characterized by a tetraploid chromosome content, LOH of 9p21 and 17p13 and p53 positivity; (iv) carcinoma in situ lesions and invasive laryngeal carcinomas showed a more unbalanced chromosome pattern and an additional 18q21 LOH. These results show that different steps in aneuploidization correlate with LOH of 9p21, 17p13 and 18q21 in early laryngeal carcinogenesis. These genomic changes could be of potential use in the diagnosis and prognosis of pre-malignant laryngeal lesions.
喉鳞状细胞癌通常由癌前病变发展而来。在本研究中,采用p53免疫组织化学以及1、7、9、17和18号染色体原位杂交技术,对喉癌前病变和恶性病变进行了分析。对激光显微切割的组织碎片进行微卫星分析,以研究9p21、17p13和18q21的杂合性缺失(LOH)。对少数病例的连续活检组织进行分析,以更详细地研究基因进展情况。观察到以下基因进展模式:(i)组织学上正常的黏膜和无恶性进展的增生性病变,所有检测染色体通常为二倍体,p53呈阴性或仅基底细胞层呈阳性,无等位基因缺失;(ii)发育异常/浸润性生长之前的增生性病变常表现为7号染色体三体以及9p21和17p13的LOH,这些病变中的小病灶有时表现为四倍体化和p53阳性;(iii)发育异常性病变的特征是染色体含量为四倍体、9p21和17p13的LOH以及p53阳性;(iv)原位癌和浸润性喉癌表现出更不平衡的染色体模式以及额外的18q21 LOH。这些结果表明,在喉癌发生早期,非整倍体化的不同阶段与9p21、17p13和18q21的LOH相关。这些基因组变化可能在喉癌前病变的诊断和预后中具有潜在用途。